<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
<meta http-equiv="Content-Language" content="en-us">
<title>About Me</title>
<meta name="GENERATOR" content="Microsoft FrontPage 6.0">
<meta name="ProgId" content="FrontPage.Editor.Document">
<link rel="File-List" href="aboutme.files/filelist.xml">

<style>
<!--
span.style51
	{color:#FFCC00}
span {
	color: #F00;
}
strong {
	font-size: 36px;
	font-family: Georgia, "Times New Roman", Times, serif;
	color: #3F0;
}
-->
</style>
<!--[if !mso]>
<style>
v\:*         { behavior: url(#default#VML) }
o\:*         { behavior: url(#default#VML) }
.shape       { behavior: url(#default#VML) }
h2
	{margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	page-break-after:avoid;
	text-autospace:none;
	font-size:12.0pt;
	font-family:"Times New Roman";
	margin-left:0in; margin-right:0in; margin-top:0in}
</style>
<![endif]--><!--[if gte mso 9]>
<xml><o:shapedefaults v:ext="edit" spidmax="1027"/>
</xml><![endif]-->
</head>

<body bgcolor="#FFFFFF">

<table border="0" cellpadding="0" cellspacing="0" width="100%">
  <tr>
    <td colspan="2" align="center"><p><strong class="style51"><a href="Hu's Lab.htm">Hu's Lab</a> (Signal Transduction and Targeted Gene Therapy)</strong></p></td>
  </tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" width="86%">
  <tr>
    <td style="border-bottom-style: solid; border-bottom-width: 1" align="right">&nbsp;</td>
  </tr>
</table>
<table width="1057" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td valign="top" width="102" style="border-left-style:none; border-left-width:medium; border-right-style:solid; border-right-width:1; border-top-style:none; border-top-width:medium; border-bottom-style:none; border-bottom-width:medium">
    <p align="center"><a target="_top" href="index.html">Hu's Homepage</a></p>
    <p align="center"><a href="Research-interest.htm">Research Interests</a></p>
    <p align="center"><a href="Lab-Member.htm">Lab Members</a></p>
    <p align="center"><a href="Lab-photo.htm">Lab News and Photoes</a></p>
    <p align="center"><a href="Publications.htm">Publications</a></p>
    <p align="center"><a href="Collaborators.htm">Collaborators</a></p>
    <p align="center"><a href="Links.htm">Useful Links </a></p>
    <p align="center"><a href="feedback.htm">Contact Information</a>&nbsp;</p><p>&nbsp;</p>
    </td>
    <td valign="top" width="1" style="border-right-style:none; border-right-width:medium; border-top-style:none; border-top-width:medium; border-bottom-style:none; border-bottom-width:medium">
    </td>
    <td width="954" height="100%" colspan="3" valign="top" style="border-right-style:none; border-right-width:medium; border-top-style:none; border-top-width:medium; border-bottom-style:none; border-bottom-width:medium; font-size: 16px;">
      <p>The challenges of discovery and translation inspire my  biomedical research. I am fascinated by the creative process of identifying  novel molecules that regulate signal transduction and gene expression. My  creativity and productivity are reflected by achievements during the past  years. The overarching goal of my lab research is to understand the novel  mechanisms underlying neural development, adult neurogenesis, neuronal  polarization, neuroregeneration, neuroinflammation, metabolic syndrome and tumorigenesis. </p>
<p>NFkB signaling is a  central and often pathogenic mediator of inflammation, immunity and neural  plasticity, that contributes to developmental <a href="images/NIBP-pathway.jpg"><img src="images/NIBP-pathway.jpg" alt="Fig.1 NIBP" width="440" height="413" align="right"></a>defects and chronic diseases including  neurodegenerative diseases, chronic inflammatory diseases, autoimmunity, and  cancer. We discovered a novel protein NIBP[NIK- and IKK2- binding protein, which enhances  cytokine-induced NFkB activation by  increasing kinase activities of IKK2 and NIK. Due to the presence of a conserved domain of Trs120, a key member of  yeast trafficking protein particle complex (TRAPPC) II, NIBP is renamed as TRAPPC9. NIBP/TRAPPC9 interacts  with the other members of TRAPPCII. It relays the  vesicle-dynactin interaction at the target membrane, allowing nascent endoplasmic  reticulum-Golgi intermediate compartment to move along the microtubules. In humans, NIBP function appears critical to neurogenesis, mental development  and neural functional integrity, because homozygous NIBP non-sense mutation is  closely correlated with autosomal recessive mental retardation and neonatal  microcephaly. In addition, homozygous deletion of the NIBP genome in humans  leads to severe developmental delay, retinal dystrophy, hearing loss, obesity, and dysmorphic  facial features. &nbsp;We envision that NIBP  plays key roles via NFkB signaling and protein trafficking. Discovering its roles  will advance current understanding of many basic cellular  processes, and provide a novel biomarker and therapeutic target for  neurodevelopmental defects, neurodegenerative diseases and cancer.</p>
<p>&nbsp;</p>
<p><strong>Ongoing  Projects:</strong><br>
</p>
      <h3> I. Developing novel NIBP  animal model and human induced pluripotent stem (iPS) cell model in order to identify </h3>
      <p>1) novel role of NIBP/NFkB signaling in cell-fate decisions driving brain and gut neurogenesis, <a href="images/NSC-Stage.jpg"><img src="NSC-stage.jpg" alt="NSC-stage" width="548" height="429" align="right"></a></p>
      <p>2) novel function of NIBP/trans-Golgi network in neurite initiation  and axonal outgrowth,</p>
      <p>3) novel role of NIBP in hypothalamic neurogenesis and energy homeostasis, and</p>
      <p> 4) novel role of NIBP signaling in HIV latent infection and HIV-associated neurocognitive disorders (HAND); </p>
      <h3>II. Manipulating neuronal and glial NFkB signaling in  animals to establish cell type-specific role of NFkB signaling that  drive the development of novel therapeutic target for neuroinflammation and neurodegenerative diseases in both central nervous system and enteric nervous system; </h3>
      <h3>III. Using CRISP/Cas9 genome editing to &ldquo;knockout&rdquo; the latent HIV provirus from  host cells, using dCas9-mediated synergistic activator to &ldquo;shock and kill&rdquo; the HIV latent  cells and using  dCas9-mediated epigenome suppressoror silence permanently   the latent reservoir; </h3>
      <h3>IV. Exploring the role and mechanism of novel exin21 in boosting the production of antibodies, mRNA vaccine, virus and recombinant proteins.</h3>
      <p><strong>Major Techniques:</strong><br>
  <img src="images/SGZ-NSC.jpg" alt="SGZ" width="466" height="369" align="right"></p>
<ul>
  <li>
    <h3>Gene editing (CRISPR/Cas)</h3>
  </li>
  <li>
    <h3>Neural stem cell and iPS cell culture</h3>
	   <li>
    <h3>Microglia-containing cerebral organoids (MCO) and vascularized MCO</h3>
  </li>
  <li>
    <h3>RNA interference</h3>
  </li>
  <li>
    <h3>AAV-mediated gene therapy</h3>
  </li>
  <li>
    <h3>Nanoparticles and virus-like particles </h3>
  </li>
  <li>
    <h3>Conditional transgenic or knockout animal model </h3>
  </li>
  <li>
    <h3>Stereotactic injection and retrovirus labeling of neural stem cells </h3>
  </li>
	 <li>
    <h3>RT-qPCR and ddPCR </h3>
  </li>
	 <li>
    <h3>Bulk and single cell RNA-seq and bioinformatics analysis</h3>
  </li>
	 <li>
    <h3>HCR-ISH and multilabeled immunohistochemistry<img src="../images/MCO.jpg" alt="" width="594" height="310" align="right"/></h3>
  </li>
  <li>
    <h3>Confocal imaging </h3>
  </li>
  <li>
    <h3>Functional assay </h3>
  </li>
  <li>
    <h3>Neural behavior test</h3>
  </li>
</ul>
<h3>&nbsp;</h3>
<p><strong><img src="HIV-animal-model.jpg" width="666" height="424"></strong></p>
<p>&nbsp;</p>
<p align="left">&nbsp;</p>
<center>
  <p align="left">&nbsp;</p>
  </center></td>
  </tr>
  <tr>
    <td rowspan="4" valign="top" style="border-left-style:none; border-left-width:medium; border-right-style:solid; border-right-width:1; border-top-style:none; border-top-width:medium; border-bottom-style:none; border-bottom-width:medium"><p>&nbsp;</p>
    <p><div align="center"><a href="http://www.amazingcounter.com"><img border="0" src="http://cc.amazingcounters.com/counter.php?i=3091638&c=9275227" alt="home page statistics"></a><br><a href="http://www.ezisp.info/high-speed/comcast.html"> Visitors </a></div>&nbsp;</p></td>
    <td rowspan="4" valign="top" style="border-right-style:none; border-right-width:medium; border-top-style:none; border-top-width:medium; border-bottom-style:none; border-bottom-width:medium"></td>
    <td valign="top" height="50%" style="border-right-style:none; border-right-width:medium; border-top-style:none; border-top-width:medium; border-bottom-style:none; border-bottom-width:medium"><img src="images/Primary neuron.jpg" width="307" height="321"><img src="images/NCE-tdT.jpg" width="450" height="321"></td>
    <td valign="top" style="border-right-style:none; border-right-width:medium; border-top-style:none; border-top-width:medium; border-bottom-style:none; border-bottom-width:medium">&nbsp;</td>
    <td valign="top" style="border-right-style:none; border-right-width:medium; border-top-style:none; border-top-width:medium; border-bottom-style:none; border-bottom-width:medium">&nbsp;</td>
  </tr>
  <tr>
    <td height="50%" colspan="3" valign="top" style="border-right-style:none; border-right-width:medium; border-top-style:none; border-top-width:medium; border-bottom-style:none; border-bottom-width:medium"><img src="images/NIBP-in ENS.jpg" width="938" height="394"></td>
  </tr>
  <tr>
    <td height="100%" colspan="3" valign="top" style="border-right-style:none; border-right-width:medium; border-top-style:none; border-top-width:medium; border-bottom-style:none; border-bottom-width:medium">&nbsp;</td>
  </tr>
  <tr>
    <td height="100%" colspan="3" valign="top" style="border-right-style:none; border-right-width:medium; border-top-style:none; border-top-width:medium; border-bottom-style:none; border-bottom-width:medium">&nbsp;</td>
  </tr>
</table>
<p align="center"><span class="style51"><a href="http://www.temple.edu/">
<span style="font-family: Times New Roman; color: #0000FF; text-decoration: underline">
TU</span></a><span lang="EN-US" style="font-size: 12.0pt; font-family: Times New Roman">
•
<a style="color: blue; text-decoration: underline; text-underline: single" href="http://www.temple.edu/medicine/">SOM</a> •
<a href="https://medicine.temple.edu/departments-centers/research-centers/center-metabolic-disease-research">
<span style="color: #0000FF; text-decoration: underline">CMDR</span></a></span></span><small>
</small><span class="style51">
<span lang="EN-US" style="font-size: 12.0pt; font-family: Times New Roman">•
<a href="http://www.sfn.org/index.cfm?pagename=home">SFN</a> • <a href="http://www.gastro.org/">AGA</a> • <a href="http://www.ddw.org/">DDW</a> 
• <a href="http://www.asbmb.org/">ASBMB</a></span></span></p>
<DIV align=left>
<TABLE height=24 cellSpacing=0 cellPadding=0 width=920 id="table1"><!-- MSTableType="layout" -->
  <TBODY>
  <TR>
    <TD width=920 height=24>
      <P style="MARGIN-TOP: 1px" align=center><FONT size=2>
		<IMG height=5 
      hspace=5 src="BD21548_3F.gif" width="99%" align=top vspace=2 
      border=0><BR></FONT><I><FONT color=#cc0000 size=2>This page does not 
      reflect an official position of Temple University</FONT></I></P></TD></TR></TBODY></TABLE></DIV>
<p><i><small>This site was last updated 8/28/2024</small></i></p>

</body>

</html>
